Company · CIK 0001709401 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Rubius Therapeutics, Inc. · RUBY
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2019 MForm 4 → | Jan 24, 5:24 pm EST | Christopher L. CarpenterChief Medical Officer | 34,843 | $2.87 | $99,999 | 34,843 | — | plan? |
| Jan 14, 2019 SForm 4 → | Jan 18, 4:36 pm EST | Robert LangerDirector | 7,500 | $14.59 | $109,444 | 0 | −100% | plan? late |
| Jan 14, 2019 MForm 4 → | Jan 18, 4:36 pm EST | Robert LangerDirector | 7,500 | $0.15 | $1,125 | 7,500 | — | plan? late |
| Nov 28, 2018 GForm 5 → | Feb 14, 2019, 5:02 pm EST | David R EpsteinDirector | 360,000 | — | — | 180,000 | — | plan? |
| Jul 20, 2018 CForm 4 → | Jul 23, 4:34 pm EDT | Flagship Ventures Fund IV General Partner LLC +8Director, 10% Owner | 33,296,526 | — | — | 2,563,703 | — | plan? |
| Jul 20, 2018 PForm 4 → | Jul 23, 4:34 pm EDT | Catherine A. SohnDirector | 2,500 | $23.00 | $57,500 | 2,500 | — | plan? |
| Jul 20, 2018 PForm 4 → | Jul 23, 4:33 pm EDT | Roger PomerantzDirector | 100 | $23.00 | $2,300 | 100 | — | plan? |
| Jul 20, 2018 PForm 4 → | Jul 23, 4:33 pm EDT | Francis M CussDirector | 10,000 | $23.00 | $230,000 | 10,000 | — | plan? |
| Jul 20, 2018 PForm 4 → | Jul 23, 4:33 pm EDT | Jonathan SymondsDirector | 25,000 | $23.00 | $575,000 | 25,000 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2019 AForm 4 → | Feb 4, 6:35 pm EST | Andrew M. OhChief Financial Officer | 115,000 | — | — | 115,000 | — | |
| Jan 31, 2019 AForm 4 → | Feb 4, 6:35 pm EST | Christopher L. CarpenterChief Medical Officer | 100,000 | — | — | 100,000 | — | |
| Jan 31, 2019 AForm 4 → | Feb 4, 6:34 pm EST | Torben Straight NissenPresident | 175,000 | — | — | 175,000 | — | |
| Jan 31, 2019 AForm 4 → | Feb 4, 6:34 pm EST | Pablo J CagnoniChief Executive Officer, Director | 100,000 | — | — | 100,000 | — | |
| Jan 22, 2019 MForm 4 → | Jan 24, 5:24 pm EST | Christopher L. CarpenterChief Medical Officer | 34,843 | — | — | 715,157 | — | |
| Jan 14, 2019 MForm 4 → | Jan 18, 4:36 pm EST | Robert LangerDirector | 7,500 | — | — | 142,500 | — | late |
| Oct 31, 2018 AForm 4 → | Nov 1, 8:11 pm EDT | Pablo J CagnoniChief Executive Officer, Director | 357,800 | — | — | 193,400 | — | |
| Jul 20, 2018 CForm 4 → | Jul 23, 4:34 pm EDT | Flagship Ventures Fund IV General Partner LLC +8Director, 10% Owner | 33,296,526 | — | — | 0 | — | |
| Jul 17, 2018 AForm 4 → | Jul 18, 4:34 pm EDT | Noubar AfeyanDirector, 10% Owner | 25,000 | — | — | 25,000 | — | |
| Jul 17, 2018 AForm 4 → | Jul 18, 4:34 pm EDT | Roger PomerantzDirector | 25,000 | — | — | 25,000 | — | |
| Jul 17, 2018 AForm 4 → | Jul 18, 4:34 pm EDT | Robert LangerDirector | 25,000 | — | — | 25,000 | — | |
| Jul 17, 2018 AForm 4 → | Jul 18, 4:33 pm EDT | Michael RosenblattDirector | 25,000 | — | — | 25,000 | — | |
| Jul 17, 2018 AForm 4 → | Jul 18, 4:33 pm EDT | Catherine A. SohnDirector | 25,000 | — | — | 25,000 | — | |
| Jul 17, 2018 AForm 4 → | Jul 18, 4:33 pm EDT | David R EpsteinDirector | 1,902,977 | — | — | 1,902,977 | — | |
| Jul 17, 2018 AForm 4 → | Jul 18, 4:32 pm EDT | Francis M CussDirector | 25,000 | — | — | 25,000 | — | |
| Jul 17, 2018 AForm 4 → | Jul 18, 4:32 pm EDT | Jonathan SymondsDirector | 25,000 | — | — | 25,000 | — |